BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24:330-340. [PMID: 30671792 DOI: 10.1007/s11605-018-04086-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Shirono T, Niizeki T, Iwamoto H, Shimose S, Suzuki H, Kawaguchi T, Kamachi N, Noda Y, Okamura S, Nakano M, Kuromatu R, Koga H, Torimura T. Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis. J Clin Med 2021;10:987. [PMID: 33801202 DOI: 10.3390/jcm10050987] [Reference Citation Analysis]
2 Ohira M, Yoshizumi T, Yugawa K, Kosai-Fujimoto Y, Inokuchi S, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Taketomi A, Mori M. Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma. Surg Today 2020;50:379-88. [PMID: 31667580 DOI: 10.1007/s00595-019-01905-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Song L, Zhu J, Li Z, Wei T, Gong R, Lei J. The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma. Cancer Manag Res 2019;11:8451-62. [PMID: 31572000 DOI: 10.2147/CMAR.S219163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Tang M, Yu XX, Huang J, Gao JL, Cen FL, Xiao Q, Fu SZ, Yang Y, Xiong B, Pan YJ, Liu YX, Feng YW, Li JX, Liu Y. Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule. World J Clin Cases 2021; 9(13): 2994-3007 [PMID: 33969085 DOI: 10.12998/wjcc.v9.i13.2994] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao J, Zhang W, Zhu YY, Zheng HY, Xu L, Zhang J, Liu SY, Li FY, Song B. Development and Validation of Noninvasive MRI-Based Signature for Preoperative Prediction of Early Recurrence in Perihilar Cholangiocarcinoma. J Magn Reson Imaging 2021. [PMID: 34296802 DOI: 10.1002/jmri.27846] [Reference Citation Analysis]
6 Yasukawa K, Shimizu A, Motoyama H, Kubota K, Notake T, Fukushima K, Ikehara T, Hayashi H, Kobayashi A, Soejima Y. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients. J Surg Oncol 2020;122:1094-105. [PMID: 32634266 DOI: 10.1002/jso.26109] [Reference Citation Analysis]
7 Shalayiadang P, Abulizi A, Ahan A, Jiang T, Ran B, Zhang R, Guo Q, Wen H, Shao Y, Aji T. Diagnosis and treatment modalities of hilar biliary duct stricture in hepatic cystic echinococcosis after endocystectomy. Parasite 2021;28:51. [PMID: 34142953 DOI: 10.1051/parasite/2021051] [Reference Citation Analysis]
8 Ruffolo LI, Jackson KM, Kuhlers PC, Dale BS, Figueroa Guilliani NM, Ullman NA, Burchard PR, Qin SS, Juviler PG, Keilson JM, Morrison AB, Georger M, Jewell R, Calvi LM, Nywening TM, O'Dell MR, Hezel AF, De Las Casas L, Lesinski GB, Yeh JJ, Hernandez-Alejandro R, Belt BA, Linehan DC. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. Gut 2021:gutjnl-2021-324109. [PMID: 34413131 DOI: 10.1136/gutjnl-2021-324109] [Reference Citation Analysis]
9 Nouri-Vaskeh M, Mirza-Aghazadeh-Attari M, Pashazadeh F, Azami-Aghdash S, Alizadeh H, Pouya P, Halimi M, Jadideslam G, Zarei M. Prognostic Impact of Monocyte to Lymphocyte Ratio in Clinical Outcome of Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Galen Med J 2020;9:e1948. [PMID: 34466618 DOI: 10.31661/gmj.v9i0.1948] [Reference Citation Analysis]